Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 36 entries
Sorted by: Best Match Show Resources per page
Serum Cystatin C can detect impaired graft function early after renal transplantation.

International journal of clinical and experimental medicine

Zhou SM, Zhao W, Lin T, Zhao ST, Wang HW.
PMID: 26629161
Int J Clin Exp Med. 2015 Sep 15;8(9):16379-83. eCollection 2015.

OBJECTIVES: To study the significance of Cystatin C (Cys C) in early detection of the graft function after renal transplantation.MATERIAL: The concentrations of Cys C, Blood urea nitrogen (BUN), Serum creatinine (SCr), and glomerular filtration rate (GFR) were measured....

Cite
Zhou SM, Zhao W, Lin T, et al. Serum Cystatin C can detect impaired graft function early after renal transplantation. Int J Clin Exp Med. 2015;8(9):16379-83
Zhou, S. M., Zhao, W., Lin, T., Zhao, S. T., & Wang, H. W. (2015). Serum Cystatin C can detect impaired graft function early after renal transplantation. International journal of clinical and experimental medicine, 8(9), 16379-83.
Zhou, Shi-Ming, et al. "Serum Cystatin C can detect impaired graft function early after renal transplantation." International journal of clinical and experimental medicine vol. 8,9 (2015): 16379-83.
Zhou SM, Zhao W, Lin T, Zhao ST, Wang HW. Serum Cystatin C can detect impaired graft function early after renal transplantation. Int J Clin Exp Med. 2015 Sep 15;8(9):16379-83. eCollection 2015. PMID: 26629161; PMCID: PMC4659049.
Copy Download .nbib Format: NLM
[History of epidemiologic methods-- cohort studies].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Qin Y, Zhan ST, Li LM.
PMID: 15231179
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):449-51.

No abstract available.

Cite
Qin Y, Zhan ST, Li LM. [History of epidemiologic methods-- cohort studies]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25(5):449-51
Qin, Y., Zhan, S. T., & Li, L. M. (2004). [History of epidemiologic methods-- cohort studies]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 25(5), 449-51.
Qin, Ying, et al. "[History of epidemiologic methods-- cohort studies]." Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi vol. 25,5 (2004): 449-51.
Qin Y, Zhan ST, Li LM. [History of epidemiologic methods-- cohort studies]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):449-51. Chinese. PMID: 15231179.
Copy Download .nbib Format: NLM
[Anatomical knowledge in Yi Xue Tong Zong].

Zhonghua yi shi za zhi (Beijing, China : 1980)

Zhai ST, Cheng YL.
PMID: 21223700
Zhonghua Yi Shi Za Zhi. 2010 Nov;40(6):328-30.

Ancient anatomy made slow progress after it experienced two peaks of development in the Song dynasty. He Jian, a military doctor of the Ming Dynasty, observed diaphragm, heart, liver, gallbladder, bladder, throat and other human organs through autopsy. He...

Cite
Zhai ST, Cheng YL. [Anatomical knowledge in Yi Xue Tong Zong]. Zhonghua Yi Shi Za Zhi. 2010;40(6):328-30
Zhai, S. T., & Cheng, Y. L. (2010). [Anatomical knowledge in Yi Xue Tong Zong]. Zhonghua yi shi za zhi (Beijing, China : 1980), 40(6), 328-30.
Zhai, Shu-Ting, and Cheng, Yuan-Lin. "[Anatomical knowledge in Yi Xue Tong Zong]." Zhonghua yi shi za zhi (Beijing, China : 1980) vol. 40,6 (2010): 328-30.
Zhai ST, Cheng YL. [Anatomical knowledge in Yi Xue Tong Zong]. Zhonghua Yi Shi Za Zhi. 2010 Nov;40(6):328-30. Chinese. PMID: 21223700.
Copy Download .nbib Format: NLM
[The factors influencing the spread of Chinese herbal medicine as reflected in the application of Sanchi (Radix Notoginseng).].

Zhonghua yi shi za zhi (Beijing, China : 1980)

Zhai ST.
PMID: 16469256
Zhonghua Yi Shi Za Zhi. 2005 Oct;35(4):238-40.

The curative effect of medicine is the principal one among so many factors that influence its spread. As an effective blood-stanching herb, Sanchi (Radix Notoginseng) is approved in nearly 20 years and is cultivated widely with its sources ensured.

Cite
Zhai ST. [The factors influencing the spread of Chinese herbal medicine as reflected in the application of Sanchi (Radix Notoginseng).]. Zhonghua Yi Shi Za Zhi. 2005;35(4):238-40
Zhai, S. T. (2005). [The factors influencing the spread of Chinese herbal medicine as reflected in the application of Sanchi (Radix Notoginseng).]. Zhonghua yi shi za zhi (Beijing, China : 1980), 35(4), 238-40.
Zhai, Shu-Ting. "[The factors influencing the spread of Chinese herbal medicine as reflected in the application of Sanchi (Radix Notoginseng).]." Zhonghua yi shi za zhi (Beijing, China : 1980) vol. 35,4 (2005): 238-40.
Zhai ST. [The factors influencing the spread of Chinese herbal medicine as reflected in the application of Sanchi (Radix Notoginseng).]. Zhonghua Yi Shi Za Zhi. 2005 Oct;35(4):238-40. Chinese. PMID: 16469256.
Copy Download .nbib Format: NLM
Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma.

International journal of ophthalmology

Liu Y, Wan ST, Zhang P, Zhang WX, Zheng JL, Lin JX, Li YP.
PMID: 25161927
Int J Ophthalmol. 2014 Aug 18;7(4):594-601. doi: 10.3980/j.issn.2222-3959.2014.04.02. eCollection 2014.

AIM: To discuss the prognostic significant of autophagy related proteins (ARPs) in retinoblastoma (RB) and to find the molecular marker to distinguish retinocytoma (RC) and RB by investigating the different expression profiling of microtubule-associated protein light chain 3 (LC3B)...

Cite
Liu Y, Wan ST, Zhang P, et al. Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma. Int J Ophthalmol. 2014;7(4):594-601doi: 10.3980/j.issn.2222-3959.2014.04.02.
Liu, Y., Wan, S. T., Zhang, P., Zhang, W. X., Zheng, J. L., Lin, J. X., & Li, Y. P. (2014). Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma. International journal of ophthalmology, 7(4), 594-601. https://doi.org/10.3980/j.issn.2222-3959.2014.04.02
Liu, Yue, et al. "Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma." International journal of ophthalmology vol. 7,4 (2014): 594-601. doi: https://doi.org/10.3980/j.issn.2222-3959.2014.04.02
Liu Y, Wan ST, Zhang P, Zhang WX, Zheng JL, Lin JX, Li YP. Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma. Int J Ophthalmol. 2014 Aug 18;7(4):594-601. doi: 10.3980/j.issn.2222-3959.2014.04.02. eCollection 2014. PMID: 25161927; PMCID: PMC4137191.
Copy Download .nbib Format: NLM
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.

Journal of skin cancer

Klein M, Lotem M, Peretz T, Zwas ST, Mizrachi S, Liberman Y, Chisin R, Schachter J, Ron IG, Iosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, Denardo GL, Denardo SJ, Casadevall A, Dadachova E, Thornton GB.
PMID: 23365757
J Skin Cancer. 2013;2013:828329. doi: 10.1155/2013/828329. Epub 2013 Jan 10.

There is a need for effective "broad spectrum" therapies for metastatic melanoma which would be suitable for all patients. The objectives of Phase Ia/Ib studies were to evaluate the safety, pharmacokinetics, dosimetry, and antitumor activity of (188)Re-6D2, a 188-Rhenium-labeled...

Cite
Klein M, Lotem M, Peretz T, et al. Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer. 2013;2013:828329doi: 10.1155/2013/828329.
Klein, M., Lotem, M., Peretz, T., Zwas, S. T., Mizrachi, S., Liberman, Y., Chisin, R., Schachter, J., Ron, I. G., Iosilevsky, G., Kennedy, J. A., Revskaya, E., de Kater, A. W., Banaga, E., Klutzaritz, V., Friedmann, N., Galun, E., Denardo, G. L., Denardo, S. J., Casadevall, A., Dadachova, E., & Thornton, G. B. (2013). Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. Journal of skin cancer, 2013828329. https://doi.org/10.1155/2013/828329
Klein, M, et al. "Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma." Journal of skin cancer vol. 2013 (2013): 828329. doi: https://doi.org/10.1155/2013/828329
Klein M, Lotem M, Peretz T, Zwas ST, Mizrachi S, Liberman Y, Chisin R, Schachter J, Ron IG, Iosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, Denardo GL, Denardo SJ, Casadevall A, Dadachova E, Thornton GB. Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer. 2013;2013:828329. doi: 10.1155/2013/828329. Epub 2013 Jan 10. PMID: 23365757; PMCID: PMC3556872.
Copy Download .nbib Format: NLM
The renal and urologic complications of inflammatory bowel disease.

Inflammatory bowel diseases

El-Serag HB, Zwas F, Bonheim NA, Cirillo NW, Appel G.
PMID: 23282807
Inflamm Bowel Dis. 1997;3(3):217-24.

SUMMARY: : Extraintestinal manifestations of inflammatory bowel disease (IBD) are common. Clinically significant renal/urologic complications occur in 10-15% of patients with IBD. In this article, we review the incidence, pathogenesis, diagnosis, and management of the various renal/urologic complications. In...

Cite
El-Serag HB, Zwas F, Bonheim NA, et al. The renal and urologic complications of inflammatory bowel disease. Inflamm Bowel Dis. 1997;3(3):217-24
El-Serag, H. B., Zwas, F., Bonheim, N. A., Cirillo, N. W., & Appel, G. (1997). The renal and urologic complications of inflammatory bowel disease. Inflammatory bowel diseases, 3(3), 217-24.
El-Serag, H B, et al. "The renal and urologic complications of inflammatory bowel disease." Inflammatory bowel diseases vol. 3,3 (1997): 217-24.
El-Serag HB, Zwas F, Bonheim NA, Cirillo NW, Appel G. The renal and urologic complications of inflammatory bowel disease. Inflamm Bowel Dis. 1997;3(3):217-24. PMID: 23282807.
Copy Download .nbib Format: NLM
Social Company by a Receptive Mating Partner Facilitates Fear Extinction.

Frontiers in neuroscience

Gao F, Huang J, Guan YF, Huang GB, Li WJ, He XY, Qiu ZC, Zhang YL, Zhao ST, Li J, Xuan A, Sun XD.
PMID: 32116509
Front Neurosci. 2020 Feb 07;14:62. doi: 10.3389/fnins.2020.00062. eCollection 2020.

Fear extinction remains an unresolved challenge for behavioral exposure therapy in patients with post-traumatic stress disorder (PTSD). Previous reports have suggested that social support from either familiar or unfamiliar same-sex partners is beneficial to attenuating fear responses during fear...

Cite
Gao F, Huang J, Guan YF, et al. Social Company by a Receptive Mating Partner Facilitates Fear Extinction. Front Neurosci. 2020;14:62doi: 10.3389/fnins.2020.00062.
Gao, F., Huang, J., Guan, Y. F., Huang, G. B., Li, W. J., He, X. Y., Qiu, Z. C., Zhang, Y. L., Zhao, S. T., Li, J., Xuan, A., & Sun, X. D. (2020). Social Company by a Receptive Mating Partner Facilitates Fear Extinction. Frontiers in neuroscience, 1462. https://doi.org/10.3389/fnins.2020.00062
Gao, Feng, et al. "Social Company by a Receptive Mating Partner Facilitates Fear Extinction." Frontiers in neuroscience vol. 14 (2020): 62. doi: https://doi.org/10.3389/fnins.2020.00062
Gao F, Huang J, Guan YF, Huang GB, Li WJ, He XY, Qiu ZC, Zhang YL, Zhao ST, Li J, Xuan A, Sun XD. Social Company by a Receptive Mating Partner Facilitates Fear Extinction. Front Neurosci. 2020 Feb 07;14:62. doi: 10.3389/fnins.2020.00062. eCollection 2020. PMID: 32116509; PMCID: PMC7018940.
Copy Download .nbib Format: NLM
Serological Detection of Rh-Del Phenotype among Rh-Negative Blood Donors at National Blood Center, Yangon, Myanmar.

Advances in hematology

Wah ST, Chi SN, Kyaing KK, Khin AA, Aung T.
PMID: 32148507
Adv Hematol. 2020 Feb 18;2020:3482124. doi: 10.1155/2020/3482124. eCollection 2020.

BACKGROUND: Red cell Rhesus (Rh) antigen expression is influenced by the genetic polymorphism of METHOD: A total of 222 Rh-negative blood donors in the National Blood Center were tested for weak D and Rh-Del by indirect antihuman globulin and...

Cite
Wah ST, Chi SN, Kyaing KK, et al. Serological Detection of Rh-Del Phenotype among Rh-Negative Blood Donors at National Blood Center, Yangon, Myanmar. Adv Hematol. 2020;2020:3482124doi: 10.1155/2020/3482124.
Wah, S. T., Chi, S. N., Kyaing, K. K., Khin, A. A., & Aung, T. (2020). Serological Detection of Rh-Del Phenotype among Rh-Negative Blood Donors at National Blood Center, Yangon, Myanmar. Advances in hematology, 20203482124. https://doi.org/10.1155/2020/3482124
Wah, Saw Thu, et al. "Serological Detection of Rh-Del Phenotype among Rh-Negative Blood Donors at National Blood Center, Yangon, Myanmar." Advances in hematology vol. 2020 (2020): 3482124. doi: https://doi.org/10.1155/2020/3482124
Wah ST, Chi SN, Kyaing KK, Khin AA, Aung T. Serological Detection of Rh-Del Phenotype among Rh-Negative Blood Donors at National Blood Center, Yangon, Myanmar. Adv Hematol. 2020 Feb 18;2020:3482124. doi: 10.1155/2020/3482124. eCollection 2020. PMID: 32148507; PMCID: PMC7049430.
Copy Download .nbib Format: NLM
The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure.

Journal of clinical medicine

Abu Ghosh Z, Zwas DR, Keren A, Elbaz-Greener G, Israeli V, Amir O, Gotsman I.
PMID: 34884277
J Clin Med. 2021 Nov 27;10(23). doi: 10.3390/jcm10235577.

BACKGROUND: The COVID-19 pandemic has adversely affected the provision of health care and disease management around the world. COVID-19 carries a high morbidity and mortality rate in elderly and people with comorbidities, including heart failure (HF). The present study...

Cite
Abu Ghosh Z, Zwas DR, Keren A, et al. The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235577.
Abu Ghosh, Z., Zwas, D. R., Keren, A., Elbaz-Greener, G., Israeli, V., Amir, O., & Gotsman, I. (2021). The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235577
Abu Ghosh, Zahi, et al. "The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235577
Abu Ghosh Z, Zwas DR, Keren A, Elbaz-Greener G, Israeli V, Amir O, Gotsman I. The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. J Clin Med. 2021 Nov 27;10(23). doi: 10.3390/jcm10235577. PMID: 34884277; PMCID: PMC8658461.
Copy Download .nbib Format: NLM
The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure.

Journal of clinical medicine

Abu Ghosh Z, Zwas DR, Keren A, Elbaz-Greener G, Israeli V, Amir O, Gotsman I.
PMID: 34884277
J Clin Med. 2021 Nov 27;10(23). doi: 10.3390/jcm10235577.

BACKGROUND: The COVID-19 pandemic has adversely affected the provision of health care and disease management around the world. COVID-19 carries a high morbidity and mortality rate in elderly and people with comorbidities, including heart failure (HF). The present study...

Cite
Abu Ghosh Z, Zwas DR, Keren A, et al. The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235577.
Abu Ghosh, Z., Zwas, D. R., Keren, A., Elbaz-Greener, G., Israeli, V., Amir, O., & Gotsman, I. (2021). The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235577
Abu Ghosh, Zahi, et al. "The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235577
Abu Ghosh Z, Zwas DR, Keren A, Elbaz-Greener G, Israeli V, Amir O, Gotsman I. The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. J Clin Med. 2021 Nov 27;10(23). doi: 10.3390/jcm10235577. PMID: 34884277.
Copy Download .nbib Format: NLM
Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure.

European journal of clinical investigation

Gotsman I, Keren A, Amir O, Zwas DR.
PMID: 34293203
Eur J Clin Invest. 2022 Jan;52(1):e13655. doi: 10.1111/eci.13655. Epub 2021 Aug 02.

BACKGROUND: Increased weight measured by body mass index is associated with better clinical outcomes in heart failure (HF). The effect of specific components of body mass on outcome is limited. We evaluated the impact of fat-free mass and fat...

Cite
Gotsman I, Keren A, Amir O, et al. Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure. Eur J Clin Invest. 2021;52(1):e13655doi: 10.1111/eci.13655.
Gotsman, I., Keren, A., Amir, O., & Zwas, D. R. (2022). Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure. European journal of clinical investigation, 52(1), e13655. https://doi.org/10.1111/eci.13655
Gotsman, Israel, et al. "Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure." European journal of clinical investigation vol. 52,1 (2022): e13655. doi: https://doi.org/10.1111/eci.13655
Gotsman I, Keren A, Amir O, Zwas DR. Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure. Eur J Clin Invest. 2022 Jan;52(1):e13655. doi: 10.1111/eci.13655. Epub 2021 Aug 02. PMID: 34293203.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 36 entries